GMDP data

PTD said a 24-patient, double-blind, placebo-controlled Phase IIa trial showed a statistically significant clinical improvement in 12 treated patients receiving a once-daily tablet of GMDP.

The Russian trial, monitored by a U.K.-based contract research organization, used a scoring system to measure the severity and extent of psoriasis. The company hasn't yet released the data. ...